Charlotte Smerdon

Charlotte Smerdon is an experienced professional in clinical operations with a focus on gene therapy and rare diseases. Currently serving as Senior Director of Clinical Operations at SpliceBio, Charlotte manages ophthalmology clinical programs dedicated to inherited retinal conditions. Previous roles include Senior Director of Clinical Operations at Purespring Therapeutics, where Charlotte directed clinical programs aimed at rare genetic kidney diseases, and Portfolio Director at Veristat, overseeing gene therapy programs for various conditions. Charlotte's extensive background includes positions at Freeline, Gilead Sciences, GSK, VIGORMED LIMITED, Amgen, Biogen Idec, and Takeda, with expertise in managing clinical trials, budget oversight, risk management, and regulatory compliance. Charlotte holds a PhD in Cell Biology from UCL and a BSc in Applied Biology from the University of Hertfordshire.